NCT03085615View on ClinicalTrials.gov

Feeding the Critically Ill During Phases of Altered Redox Status

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

June 4, 2018

Study Completion Date

October 13, 2018

Conditions
Acute Respiratory Distress SyndromeOxidative StressEuthyroid Sick SyndromesSystemic Inflammatory Response Syndrome
Interventions
OTHER

Jevity 1.5

Jevity 1.5 is an enteral nutrition product delivering 1.5 kcals/mL and 0.06 g protein/mL.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
collaborator

American Society for Parenteral and Enteral Nutrition

OTHER

collaborator

Rush University Medical Center

OTHER

lead

University of Illinois at Chicago

OTHER

NCT03085615 - Feeding the Critically Ill During Phases of Altered Redox Status | Biotech Hunter | Biotech Hunter